The impact of REACH authorisation: Costs and benefits

Promoted content

REACH is the European Regulation on Registration, Evaluation, Authorisation and Restriction of Chemicals. It entered into force in 2007, replacing the former legislative framework for chemicals in the EU. The main aims of REACH are to ensure a high level of protection for human health and the environment, including the promotion of alternative test methods, as well as the free circulation of substances on the internal market and the enhancement of competitiveness and innovation.

The REACH Regulation provides for regular reporting on the implementation of REACH, to be carried out by member states, the European Commission and the European Chemicals Agency (ECHA) to monitor progress in the achievement of the objectives of the Regulation, identify needs for adjustment and propose recommendations to improve the REACH implementation.

The European Commission has to report on the functioning of REACH by 1 June 2017 and an evaluation will be conducted under the REFIT programme of the Commission. The REFIT evaluation will cover the five compulsory evaluation criteria (effectiveness, efficiency, relevance, coherence and EU added value) and put emphasis on potentials for burden reduction and simplification.

The REACH report 2017 consultation strategy aims at gathering further evidence linked to REACH implementation which will complement the evidence gathered through regular consultation, desk research and analysis of available information (e.g. member state reports, ECHA reports, other information sources). Among the studies planned in order to gather further evidence is a Study on the impact of REACH Authorization.

The aim of this event was to bring together stakeholders from industry, the European Parliament, the European Commission and other actors to discuss the European Commission study on the impact of REACH Authorization and to reflect on the following key issues:

  • What are the costs and benefits of REACH Authorization?
  • What are the first experiences of SMEs that have already submitted applications on their own or as part of a Consortium?
  • Which changes can be observed in the market structure i.e. relocation, concentration effects
  • What are the potential drawbacks and benefits of substitution?
  • The way forward and REACH beyond 2018.

Subscribe to our newsletters